Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Contraindications and Precautions for Botox (Botulinum Toxin)

Medication Interactions

  • Aminoglycosides should be used with caution as they may potentiate the neuromuscular blocking effects of botulinum toxin, according to the Centers for Disease Control and Prevention (CDC) 1, 2
  • Magnesium supplements or infusions should be avoided as magnesium is a competitive inhibitor of presynaptic calcium-dependent acetylcholine release, as recommended by the CDC 1, 2
  • Calcium-channel blockers (e.g., verapamil, nifedipine, diltiazem) may interact with aminoglycosides to produce complete neuromuscular blockade, as reported by the CDC 1, 2
  • Clindamycin and tetracyclines should be used cautiously as they may potentiate neuromuscular blockade, according to the CDC 1, 2
  • Monoamine oxidase inhibitors have been associated with increased botulism-induced mortality in animal studies, as noted by the CDC 1, 2

Special Populations

  • Limited data exists on the safety of botulinum toxin during pregnancy and breastfeeding, as stated by the CDC 1
  • The high molecular weight of botulinum toxin (150,000 daltons) might prevent its passage into breast milk, according to the CDC 1
  • Case reports suggest that breastfeeding may be safe in mothers who have received therapeutic botulinum antitoxin for botulism, but data is limited, as reported by the CDC 1

Clinical Decision Making

  • Clinicians should evaluate for relative contraindications (neuromuscular disorders, interacting medications) when considering botulinum toxin treatment, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1
  • The American Academy of Otolaryngology-Head and Neck Surgery suggests assessing the risk-benefit ratio, particularly in patients with conditions that may increase sensitivity to botulinum toxin 3
  • The American Academy of Otolaryngology-Head and Neck Surgery recommends using the lowest effective dose when treating patients with relative contraindications 3
  • Clinicians should monitor patients closely for adverse effects, particularly those with risk factors, as advised by the CDC 1
  • For therapeutic indications like spasmodic dysphonia or post-stroke spasticity, the benefits often outweigh the risks when proper precautions are taken, according to the American Academy of Otolaryngology-Head and Neck Surgery and the American College of Physicians 3, 4, 5

REFERENCES

3

clinical practice guideline: hoarseness (dysphonia) (update). [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2018

4

clinical practice guideline: hoarseness (dysphonia) (update). [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2018